Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

Author： Dillman Robert O Cornforth Andrew N Nistor Gabriel

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.5, 2013-08, pp. : 643-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptide-based vaccines for cancer immunotherapy

By Brinkman Joeli A Fausch Steven C Weber Jeffrey S Kast W Martin

Expert Opinion on Biological Therapy, Vol. 4, Iss. 2, 2004-02 ,pp. : 181-198

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell-based active specific immunotherapy for malignant glioma

By Parajuli Prahlad Mathupala Saroj Mittal Sandeep Sloan Andrew E

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 439-448

Informa Healthcare

Access to resources Recommend Favorite

Prostate-specific antigen vaccines for prostate cancer

By Hörig Heidi Lee Christopher SD Kaufman Howard L

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 395-408

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell fusion vaccines for cancer immunotherapy

By Rosenblatt Jacalyn Kufe Donald Avigan David

Expert Opinion on Biological Therapy, Vol. 5, Iss. 5, 2005-05 ,pp. : 703-715

Informa Healthcare

Access to resources Recommend Favorite

Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines

By Mocellin S. Rossi C.R. Nitti D. Lise M. Marincola F.M.

Biochimica et Biophysica Acta (BBA)/Reviews on Cancer, Vol. 1653, Iss. 2, 2003-12 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite